| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.29 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |